Results for terapiforløb translation from Danish to English

0 % af de mandlige forsøgspersoner i det første terapiforløb.
in patients previously treated with chemotherapy, the initial dose is

3% af de mandlige forsøgspersoner i det første terapiforløb.
10 subjects in the first cycle of therapy.

i lyset af de begrænsede oplysninger bør patienter med nedsat nyrefunktion overvåges omhyggeligt under terapiforløb med bexaroten.
in view of the limited data, patients with renal insufficiency should be monitored carefully while on bexarotene therapy.

patienter med symptomatisk hypothyroidisme, som undergik et terapiforløb med bexaroten, er blevet behandlet med thyroideahormontilskud, hvilket afhjalp symptomerne.
patients with symptomatic hypothyroidism on bexarotene therapy have been treated with thyroid hormone supplements with resolution of symptoms.

0% af de mandlige forsøgspersoner og grad 4 thrombocytopeni hos 1% af de kvindelige vs.0% af de mandlige forsøgspersoner i det første terapiforløb.
in a study of 288 subjects with newly diagnosed glioblastoma multiforme, grade 4 neutropenia occurred in 3% of female vs 0% of male subjects and grade 4 thrombocytopenia in 1% of female vs 0% of male subjects in the first cycle of therapy.

patienter bør rådes til at mindske udsættelsen for sollys og til at undgå solarier og højfjeldssole under terapiforløb med bexaroten, idet in vitro-data antyder, at bexaroten muligvis har en lysfølsomhedsfremmende virkning.
patients should be advised to minimise exposure to sunlight and avoid sun lamps during therapy with bexarotene, as in vitro data indicate that bexarotene may potentially have a photosensitising effect.

det anbefales, at trombocyttallet overvåges regelmæssigt i de første 8 uger af terapiforløbet.
it is recommended that the platelet count is regularly monitored during the first 8 weeks of therapy.